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The cornea is a complex multilayered structure whose optical clarity depends on the precise arrangement of the constituent parts. Beneath the surface epithelium lies the main bulk of the cornea, which is composed of collagen fibrils in a surrounding protective matrix of proteoglycan and structural glycoproteins. The collagen comprises 60% of the dry weight of the cornea, and it has been shown that in certain conditions associated with loss of corneal substance, the collagen is attacked by a variety of enzymes, loosely called collagenases.
Since Gross & Lapiere (1962) first reported their series of studies showing that collagenolytic enzymes were present in tissues and could work at physiological pHs, a number of authors have shown that it was possible to inhibit lysis of collagen with substances such as sodium edetate in an experimental model using tissue cultures of epithelial and stromal explants on collagen substrates. Brown et al. (1969) first showed that the ulcerated tissue of alkali-burned cornet had considerable collagenolytic activity, and by perfusing alkali-burned rabbit cornea twice daily with cysteine and sodium edetate they were able to reduce ulceration by 70 %. However, these chemicals, particularly sodium edetate, produced considerable conjunctival irritation. Subsequent studies by Itoi et al. (1969) showed that there was no inhibition of collagenase activity using cysteine at levels below those toxic to the epithelium. Brown & Weller (1970) showed in human studies that cysteine was effective in preventing corneal ulceration in 80% of alkali-burned eyes and sodium edetate in 35%, and that sodium calcium edetate was quite ineffective.
The mechanism of inhibition of collagenase was shown to be related partly to chelation of metallic ions, including calcium and zinc, such inhibition being reversible on addition of higher concentrations of the necessary ions, but also partly irreversible, resulting from reduction of disulphide bonds in collagenase with subsequent binding to the SH site liberated. More recent studies have shown the importance of stromal proteoglycans in alkali burns and the early loss of these substances when corneal pathological changes ensue. Furthermore, crude preparations of corneal proteoglycans were shown to inhibit collagenase, although purified preparations of heparin, chondroitin sulphate and keratan sulphate were ineffective. Francois et al. (1973) published findings in the treatment of various types of corneal pathological changes using penicillamine, and we wish to report here our experience using this compound in the treatment of experimentally induced alkali burns in rabbits, and also in the treatment of Mooren's ulceration in human subjects.
Formulation of a Topical Preparation ofPenicillamine
Difficulty was experienced in obtaining a suitable solution for instillation into the eye, since a 2% solution of penicillamine in water has a pH of 1.85. A variety of buffer solutions were tried to prepare a solution avoiding this unacceptably low pH, and a 2 % solution in compound lotion of borax and sodium bicarbonate was found to have a pH of 8.65. However, at this pH there was a 90 % loss of activity in 11 days, and therefore a compromise was achieved with decreased quantities of the buffering agents to achieve a pH of 4.0-4.5, comparable to a miotic drop, such as pilocarpine 4%, at which over 80% of activity remained after three weeks. This topical preparation was used to treat the cornea in the following experiments in which a controlled alkali burn was induced in one eye of rabbits, which were then treated either with Chloromycetin drops 0.5 % 5 times daily as a control group or were treated with 2 % penicillamine drops 5 times daily.
The control group all developed severe corneal opacities and vascularization, 40 % of the cornea perforating. In the penicillamine-treated group there was less opacity and vascularization, and the corneal epithelium appeared to regenerate or progress across the epithelial defect a little faster than in the control group. No corneal perforation occurred in the penicillamine-treated eyes, and there was a striking reduction in the mucoid discharge which normally follows chemical burns of the conjunctiva and cornea. The number of animals involved was too small for any statistical evaluation, but the difference in the frequency of corneal perforation in the two groups was significant and confirmed the results of earlier authors employing other collagenase inhibitors.
Mooren's Ulcer This is a rare, chronic, painful, superficial ulceration of unknown etiology, occurring in old people, bilateral in 25% of cases, resulting in progressive marginal guttering and ulcerations which may extend around the entire periphery of the cornea, leaving only a small central island, or involving finally the whole cornea. The active ulceration is accompanied by an inflammatory swelling of the tissue around the periphery of the cornea, and this limbitis appears to be an im-portant component of the condition. High levels of collagenolytic activity have been demonstrated in explants from the edges of these ulcers, and conflicting reports have appeared concerning the value of various collagenase inhibitors in treatment.
Relatively few cases are available for treatment, but in one bilateral case it has been possible to make controlled observations, treating one eye only with penicillamine. Inhibition of the complex enzyme systems which probably involve not only collagenase, but also neutral proteases and other enzymes liberated from polymorphs and other inflammatory cells, requires a steady concentration of the inhibiting substance, which is difficult to achieve by conventional topical therapy using eye drops. For this reason the penicillamine has been applied by means of a constant delivery device (Ocusert). Similar devices are at present undergoing trial in chronic glaucoma and have been shown to provide very predictable steady concentrations of miotics in the precorneal film and on the surface of the eye.
Treatment of one eye only in a patient with bilateral Mooren's ulceration showed that penicillamine had a potent anti-inflammatory effect, rapidly decreasing the limbitis and associated inflammation in the conjunctiva. There also appeared to be an arrest of the corneal ulceration and filling in of the gutter. However, in the patient treated with the constant delivery device and in one other treated with hourly drops of penicillamine, these beneficial effects were also accompanied by some disturbance of the central cornea, where epithelial and stromal cedema with slight increase in corneal thickness were suggestive of a possible reversible toxic effect on the endothelium. Similar toxic changes have been observed in experimental animals treated intensively with other topical chelating agents and may represent the effect on the endothelial cells of reduction of essential ions such as calcium, magn-ftium and zinc (Obenberger, personal communication).
Conclusions
In Mooren's ulceration penicillamine seems to offer some beneficial effect in controlling the local inflammatory response and arresting the ulceration, but the rarity of the condition and its unpredictable time course make it difficult to control any observations. However, in chemical injuries penicillamine appears to have a distinct anti-inflammatory and anti-mucus-secreting effect, as well as controlling the enzyme-related corneal destruction. It has been shown that a reliable animal model is available, and since alkali burns of the cornea occur quite frequently in patients, we hope to be able to set up a coded prospective trial to study these effects further.
